Position in QGEN
as of Mar 31, 2026
· filed May 22, 2026
Position Value
$4,451,527
-$2,171,969 QoQ
Shares Held
111,177
-24.5% QoQ
Ownership
0.054%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 50%
Shared 0%
None 50%
Common Shares in QGEN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026SEGALL BRYANT & HAMILL, LLC holds $77,160,581 across 6 Diagnostics & Research names. QGEN ranks #6 (5.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GH |
Guardant Health, Inc.
|
232,222 | $21,450,346 | |
| 2 | VCYT |
Veracyte, Inc.
|
591,488 | $19,051,828 | |
| 3 | RDNT |
RadNet, Inc.
|
301,812 | $16,868,272 | |
| 4 | NEO |
Neogenomics Inc
|
1,133,026 | $8,407,052 | |
| 5 | TMO |
Thermo Fisher Scientific Inc.
|
14,102 | $6,931,556 | |
| 6 | QGEN |
Qiagen N.V.
This page
|
111,177 | $4,451,527 |
All Filings in QGEN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,451,527 | 111,177 | Shares | Sole | 2026-05-22 | |
| 2025-12-31 | $6,623,496 | 147,287 | Shares | Sole | 2026-02-13 | |
| No filing history on record for this holder in this stock. | ||||||